The BEST3 Trial is a Cluster Randomised Controlled Trial comparing the Cytosponge™-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care. The following types of the samples are collected as part of the Trial methodology: • Cytosponge™ samples • Saliva samples (TFF3-positive Cytosponge™ cases) • Endoscopic biopsy samples including gastric cardia and clinically-indicated oesophageal biopsies Cytosponge™ and endoscopic biopsy samples will be further processed into FFPE blocks and tissue sections.
- Fit and well (finding)
Cambridge University Hospitals NHS Foundation Trust
Addenbrookes Hospital, Hills Rd
Last Updated: 04/05/2020
|Year||Access Requests Received||Access Requests Approved|